Usa Washington covid-19 experts vaccine Usa Washington

Moderna, J&J COVID-19 booster shots: FDA panel meets to review data

Reading now: 316

WASHINGTON - A panel of independent advisers to the U.S. Food and Drug Administration will convene on Thursday and Friday to review data and vote on whether the millions of Americans who received the Moderna or Johnson & Johnson COVID-19 vaccine should get a booster shot.

The FDA’s Vaccines and Related Biological Products Advisory Committee, scheduled to meet both days from 8:30 a.m. to 5 p.m. ET, is the first step in a review process of deciding whether the extra doses should be dispensed, and if so, who should get them and when.

Experts will discuss whether a third shot of Moderna’s two-dose vaccine should contain just half the original dose and what’s the best timing for a second shot of the single-dose J&J vaccine.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News